United States Federal Circuit

In a patent case involving an application relating to methods of treating or preventing influenza by administering the drug zanamivir by oral inhalation, the Patent Trial and Appeal Board's decision upholding the examiner's rejection of all pending claims is affirmed where the Board correctly affirmed the examiner’s rejection of all pending claims as obvious.

Appellate Information

• Published 2016/10/18

Judges

• PROST

Court

• United States Federal Circuit

Counsel